Transient N-glycosylation abnormalities likely due to a de novo loss-of-function mutation in the delta subunit of coat protein I.


Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
07 2019
Historique:
received: 02 01 2019
revised: 24 04 2019
accepted: 24 04 2019
pubmed: 11 5 2019
medline: 9 7 2020
entrez: 11 5 2019
Statut: ppublish

Résumé

Accurate glycosylation of proteins is essential for their function and their intracellular transport. Numerous diseases have been described, where either glycosylation or intracellular transport of proteins is impaired. Coat protein I (COPI) is involved in anterograde and retrograde transport of proteins between endoplasmic reticulum and Golgi, where glycosylation takes place, but no association of defective COPI proteins and glycosylation defects has been described so far. We identified a patient whose phenotype at a first glance was reminiscent of PGM1 deficiency, a disease that also affects N-glycosylation of proteins. More detailed analyses revealed a different disease with a glycosylation deficiency that was only detectable during episodes of acute illness of the patient. Trio-exome analysis revealed a de novo loss-of-function mutation in ARCN1, coding for the delta-COP subunit of COPI. We hypothesize that the capacity of flow through Golgi is reduced by this defect and at high protein synthesis rates, this bottleneck also manifests as transient glycosylation deficiency.

Identifiants

pubmed: 31075182
doi: 10.1002/ajmg.a.61190
doi:

Substances chimiques

Coat Protein Complex I 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1371-1375

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Janine Reunert (J)

Department of Pediatrics, University Hospital of Muenster, Muenster, Germany.

Stephan Rust (S)

Department of Pediatrics, University Hospital of Muenster, Muenster, Germany.

Marianne Grüneberg (M)

Department of Pediatrics, University Hospital of Muenster, Muenster, Germany.

Anja Seelhöfer (A)

Department of Pediatrics, University Hospital of Muenster, Muenster, Germany.

Daniel Kurz (D)

Department of Paediatrics, Olgahospital, Stuttgart, Germany.

Volker Ocker (V)

Department of Paediatrics, Olgahospital, Stuttgart, Germany.

Dorothea Weber (D)

Gemeinschaftspraxis für Kinderheilkunde, Bensheim, Germany.

Ralph Fingerhut (R)

Swiss Newborn Screening Laboratory and Division of Metabolism, Children's Research Centre, University Children's Hospital Zurich, Zurich, Switzerland.

Thorsten Marquardt (T)

Department of Pediatrics, University Hospital of Muenster, Muenster, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH